001     201340
005     20240625095115.0
024 7 _ |2 doi
|a 10.1021/ic1016752
024 7 _ |2 ISSN
|a 0020-1669
024 7 _ |2 ISSN
|a 1520-510X
024 7 _ |2 WOS
|a WOS:000283810800058
037 _ _ |a FZJ-2015-03637
082 _ _ |a 540
100 1 _ |0 P:(DE-HGF)0
|a Binolfi, Andrés
|b 0
245 _ _ |a Bioinorganic Chemistry of Parkinson’s Disease: Structural Determinants for the Copper-Mediated Amyloid Formation of Alpha-Synuclein
260 _ _ |a Washington, DC
|b American Chemical Society
|c 2010
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1435067074_32639
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (PD). A central, unresolved question in the pathophysiology of PD relates to the role of AS-metal interactions in amyloid fibril formation and neurodegeneration. Our previous works established a hierarchy in alpha-synuclein-metal ion interactions, where Cu(II) binds specifically to the protein and triggers its aggregation under conditions that might be relevant for the development of PD. Two independent, non-interacting copper-binding sites were identified at the N-terminal region of AS, with significant difference in their affinities for the metal ion. In this work we have solved unknown details related to the structural binding specificity and aggregation enhancement mediated by Cu(II). The high-resolution structural characterization of the highest affinity N-terminus AS-Cu(II) complex is reported here. Through the measurement of AS aggregation kinetics we proved conclusively that the copper-enhanced AS amyloid formation is a direct consequence of the formation of the AS-Cu(II) complex at the highest affinity binding site. The kinetic behavior was not influenced by the His residue at position 50, arguing against an active role for this residue in the structural and biological events involved in the mechanism of copper-mediated AS aggregation. These new findings are central to elucidate the mechanism through which the metal ion participates in the fibrillization of AS and represent relevantprogress in the understanding of the bionorganic chemistry of PD.
536 _ _ |0 G:(DE-HGF)POF2-899
|a 899 - ohne Topic (POF2-899)
|c POF2-899
|x 0
|f POF I
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |0 P:(DE-HGF)0
|a Rodriguez, Esaú E.
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Valensin, Daniela
|b 2
700 1 _ |0 P:(DE-HGF)0
|a D’Amelio, Nicola
|b 3
700 1 _ |0 P:(DE-Juel1)146009
|a Ippoliti, Emiliano
|b 4
|u fzj
700 1 _ |0 P:(DE-HGF)0
|a Obal, Gonzalo
|b 5
700 1 _ |0 P:(DE-HGF)0
|a Duran, Rosario
|b 6
700 1 _ |0 P:(DE-HGF)0
|a Magistrato, Alessandra
|b 7
700 1 _ |0 P:(DE-HGF)0
|a Pritsch, Otto
|b 8
700 1 _ |0 P:(DE-HGF)0
|a Zweckstetter, Markus
|b 9
700 1 _ |0 P:(DE-HGF)0
|a Valensin, Gianni
|b 10
700 1 _ |0 P:(DE-Juel1)145614
|a Carloni, Paolo
|b 11
|u fzj
700 1 _ |0 P:(DE-HGF)0
|a Quintanar, Liliana
|b 12
700 1 _ |0 P:(DE-HGF)0
|a Griesinger, Christian
|b 13
700 1 _ |0 P:(DE-HGF)0
|a Fernández, Claudio O.
|b 14
|e Corresponding Author
773 _ _ |0 PERI:(DE-600)1484438-2
|a 10.1021/ic1016752
|g Vol. 49, no. 22, p. 10668 - 10679
|n 22
|p 10668 - 10679
|t Inorganic chemistry
|v 49
|x 1520-510X
|y 2010
856 4 _ |u https://juser.fz-juelich.de/record/201340/files/ic1016752.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201340/files/ic1016752.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201340/files/ic1016752.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201340/files/ic1016752.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201340/files/ic1016752.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201340/files/ic1016752.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:201340
|p VDB
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)146009
|a Forschungszentrum Jülich GmbH
|b 4
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)145614
|a Forschungszentrum Jülich GmbH
|b 11
|k FZJ
913 2 _ |0 G:(DE-HGF)POF3-899
|1 G:(DE-HGF)POF3-890
|2 G:(DE-HGF)POF3-800
|a DE-HGF
|b Forschungsbereich Materie
|l Forschungsbereich Materie
|v ohne Topic
|x 0
913 1 _ |0 G:(DE-HGF)POF2-899
|1 G:(DE-HGF)POF2-890
|2 G:(DE-HGF)POF2-800
|a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|v ohne Topic
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)1150
|2 StatID
|a DBCoverage
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)GRS-20100316
|k GRS
|l GRS
|x 0
920 1 _ |0 I:(DE-Juel1)IAS-5-20120330
|k IAS-5
|l Computational Biomedicine
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)GRS-20100316
980 _ _ |a I:(DE-Juel1)IAS-5-20120330
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)INM-9-20140121
981 _ _ |a I:(DE-Juel1)IAS-5-20120330


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21